Sparta Biomedical

Active

Our mission is to treat osteoarthritis and get people moving without pain

What it does

"Sparta Biomedical is dedicated to revolutionizing osteoarthritis treatment and improving mobility for individuals suffering from joint pain. The company is pioneering the development of Galene, a groundbreaking chemically engineered cartilage platform designed to address the degeneration of joint cartilage. By creating cartilage-like implants for key joints in the body, Sparta aims to alleviate the personal, economic, and societal burdens associated with osteoarthritis and joint injuries. Comprised of a diverse team with extensive experience in pharmaceuticals, medical technology, and engineering, Sparta is committed to enhancing the standard of care for osteoarthritis patients and restoring their quality of life."

Its site says now · captured 2026-08-23

Sparta Biomedical: Chemically Engineered Cartilage Implants

Sparta Biomedical is developing Hyalos, the first-of-its-kind chemically engineered cartilage platform, to treat osteoarthritis and restore pain-free movement across shoulder, knee, hip, ankle, and other joints.

Next to it in Healthcare and bio · cartilage regeneration biotech

  • Nunatak BiotechTechstars TS 2024

    Home | Nunatak

  • Opal TherapeuticsTechstars TS 2024

    Opal Therapeutics | Advance Women's Health Today

  • Syndicate BioTechstars TS 2024
  • Xias BioSOSV SOSV IndieBio NY 07

    Replacing Animal Proteins

  • AGelity BiomechanicsPlug and Play PnP 2025

    Agelity Biomechanics develops implants addressing cartilage repair for knee osteoarthritis using innovative technology.

  • Augment BiologicsSOSV SOSV IBSF 25H2 2025

    Glycosylation by Design, Not Chance.

  • NephrogenTechstars TS 2025

    Nephrogen

  • Door PharmaPlug and Play PnP 2025

    Door Pharma is a discovery phase biotech company that focuses on virus structural proteins as antiviral targets. The hypothesis underlying our work is that formation of an infectious virus requires the right interplay between viral components.